News & Updates

Treatment with dulaglutide is both effective and safe in Asians with type 2 diabetes mellitus (T2DM), a recent meta-analysis has found.

Coinfection of tuberculosis (TB) among people with HIV initiating antiretroviral therapy (ART) aggravates the risk of death, a recent study has found.

Foetal growth deceleration and high foetoplacental vascular resistance both contribute to an increased risk of prehypertension and hypertension in children, a study has found.

A 23-year longitudinal follow-up in a population-based cohort has shown a slowly progressive trend in nonalcoholic fatty liver disease (NAFLD), with liver-related outcomes affecting only a small number of people, reports a recent study.

The combination of nivolumab, ipilimumab, and cabozantinib improved progression-free survival (PFS) in patients with previously untreated, advanced renal cell carcinoma (RCC) of intermediate or poor risk as per IMDC* criteria, results of the phase III COSMIC-313 trial showed.